Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset
Authors:
- 28 March 2003
- journal article
- research article
- Published by Hindawi Limited in Pediatric Diabetes
- Vol. 4 (1) , 10-18
Abstract
Methods: We examined monocyte prostaglandin synthase 2 (PGS2/COX2) expression in individuals at risk for or with type 1 diabetes including: (i) 58 established type 1 and 2 diabetic patients; (ii) 34...Keywords
This publication has 22 references indexed in Scilit:
- Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitusJournal of Clinical Investigation, 1999
- Induction of Prostaglandin Release from Macrophages by Bacterial EndotoxinClinical Infectious Diseases, 1999
- PGE 2 , IL‐1 β, and TNF‐α Responses in Diabetics as Modifiers of Periodontal Disease ExpressionAnnals of Periodontology, 1998
- Susceptibility to type I diabetes: HLA-DQ and DR revisitedImmunology Today, 1996
- Beta-Cell Autoantibodies in Infants and Toddlers without IDDM Relatives: Diabetes Autoimmunity Study in the Young (DAISY)Journal of Autoimmunity, 1996
- Yes, but do they still get headaches?Cell, 1995
- Differential measurement of constitutive (COX-1) and inducible (COX-2) cyclooxygenase expression in human umbilical vein endothelial cells using specific immunometric enzyme immunoassaysBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin‐2European Journal of Immunology, 1995
- Prostaglandin E2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways.Journal of Experimental Medicine, 1993
- Increased prostaglandin synthesis in childhood diabetes mellitusThe Journal of Pediatrics, 1979